The last PD1-VAXX trial saw a grade 5 toxicity (the treatment killed a patient) and was terminated early (recruiting roughly 25% of the planned patient population) with no update provided to shareholders.
That's what I'd call a shelved trial?
Ann: 1st Australian site activated PD1-Vaxx Neo-POLEM Ph II trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.010(3.13%) |
Mkt cap ! $67.56M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 30.5¢ | $610.1K | 1.967M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 224601 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 90678 | 9 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |